摘要
目的评价冠脉临界病变患者药物治疗或介入治疗的疗效。方法对2003年7月至2004年12月在上海市胸科医院心内科行冠脉造影(CAG)显示病变血管狭窄程度<50%的84例冠心病患者资料进行分析。所有患者随访6～12个月,记录主要不良心血管事件(MACE:包括心源性死亡、非致死性心梗、心绞痛复发、因支架内再狭窄再次血运重建)。结果4例患者因症状典型、术前负荷试验为阳性、实验室检查异常,CAG发现病变位于LAD,狭窄程度50%左右,考虑不稳定斑块可能,予以介入治疗(PCI)。所有患者住院期间无MACE发生。4例PCI治疗患者术后症状改善,2～3个月后复查运动平板试验均转为阴性。随访期间有2例患者发生MACE事件(2.4%)。结论对于存在多种高危因素的冠脉临界病变的患者,PCI治疗可能优于药物治疗,随访的结果显示PCI治疗将有助于改善患者的生活质量,并减少MACE事件的发生。
Objective To evaluate the effect of PCI and drug treatment in borderline lesion. Methods 84 CHD patients whose lesion stenosis was about 50% were retrospectively analysed during Jul. 2003 to Dec. 2004. Patients were follow-up in 6 to 12 months and recorded MACE （death, AMI, angina relapse, restenosis instent）. Results 4 patients with borderline lesion in LAD got PCI because of typical symptom and positive exercise test. 2 month after implanting stent, they were free from the symptom and the exercise test result were negative. There was no MACE in hospital. During the follow-up, 2 patients （2.4%） had MACE. Conclusion Those borderline lesion patients who had multiple coronary risk factors may get benefit from PCI, which could improve patients＂ living quality and reduce MACE.
出处
《中国心血管病研究》
CAS
2006年第9期673-674,共2页
Chinese Journal of Cardiovascular Research
关键词
临界病变
血管形成术
经腔
经皮冠状动脉
药物疗法
Coronary borderline lesion
Angioplasty,transulminal,percutaneous coronary
Drug therapy
